The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Human Anti-Animal Antibody Interferences in Immunological Assays
Open accessAbstract
Purpose: The scope and significance of human anti-animal antibody interference in immunological assays is reviewed with an emphasis on human anti-animal immunoglobulins, particularly human anti-mouse antibodies (HAMAs). Issues: Anti-animal antibodies (IgG, IgA, IgM, IgE class, anti-isotype, and anti-idiotype specificity) arise as a result of iatrogenic and noniatrogenic causes and include human anti-mouse, -rabbit, -goat, -sheep, -cow, -pig, -rat, and -horse antibodies and antibodies with mixed specificity. Circulating antibodies can reach gram per liter concentrations and may persist for years. Prevalence estimates for anti-animal antibodies in the general population vary widely and range from <1% to 80%. Human anti-animal antibodies cause interferences in immunological assays. The most common human anti-animal antibody interferent is HAMA, which causes both positive and negative interferences in two-site mouse monoclonal antibody-based assays. Strategies to prevent the development of human anti-animal antibody responses include immunosuppressant therapy and the use of humanized, polyethylene glycolylated, or Fab fragments of antibody agents. Sample pretreatment or assay redesign can eliminate immunoassay interferences caused by anti-animal antibodies. Enzyme immunoassays, immunoradiometric assays, immunofluorescence, and HPLC assays have been designed to detect HAMA and other anti-animal antibodies, but intermethod comparability is complicated by differences in assay specificity and lack of standardization. Conclusions: Human anti-animal antibodies often go unnoticed, to the detriment of patient care. A heightened awareness on the part of laboratory staff and clinicians of the problems caused by this type of interference in routine immunoassay tests is desirable. Efforts should be directed at improving methods for identifying and eliminating this type of analytical interference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The uses and properties of PEG-linked proteins.
Delgado, C., Francis, G. E., & Fisher, D. (1992) · PubMed · Cited by 420
Discombe, G. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91898-4 · Cited by 376
Heterophilic antibodies: a problem for all immunoassays.
Boscato, L. M., & Stuart, M. C. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.1.27 · Cited by 300
Use of porcine factor VIII in the treatment of patients with acquired hemophilia
Morrison, A., Ludlam, C., & Kessler, C. (1993) · Blood · doi:10.1182/blood.v81.6.1513.1513 · Cited by 254
Immunogenicity and Allergenic Potential of Animal and Human Insulins
Schernthaner, G. (1993) · Diabetes Care · doi:10.2337/diacare.16.3.155 · Cited by 247
Incidence and specificity of interference in two-site immunoassays.
Boscato, L. M., & Stuart, M. C. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.8.1491 · Cited by 208
Goldenberg, D. M., Horowitz, J. A., Sharkey, R. M., Hall, T. C., Murthy, S., Goldenberg, H., Lee, R. E., Stein, R., Siegel, J. A., & Izon, D. O. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.548 · Cited by 199
Kuus-Reichel, K., Grauer, L. S., Karavodin, L. M., Knott, C., Krusemeier, M., & Kay, N. E. (1994) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.4.365-372.1994 · Cited by 184
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion
Grossbard, M., Freedman, A. S., Ritz, J., Coral, F., Goldmacher, V. S., Eliseo, L. J., Spector, N., Dear, K. B. G., Lambert, J., & Blättler, W. A. (1992) · Blood · doi:10.1182/blood.v79.3.576.576 · Cited by 171
SPECIFICITY OF THE DIRECT SOLID-PHASE RADIOIMMUNOASSAY FOR DETECTION OF HEPATITIS-B ANTIGEN
Prince, A. M., Jass, D., Brotman, B., & Ikram, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91674-7 · Cited by 153
The use of monoclonal antibodies and antibody fragments in the imaging of infectious lesions
Becker, W., Goldenberg, D. M., & Wolf, F. (1994) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(05)80228-4 · Cited by 148
Antibodies as cytotoxic therapy.
Dillman, R. O. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.7.1497 · Cited by 126
Thompson, R. J., Jackson, A. P., & Langlois, N. E. I. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.3.476 · Cited by 122
Murray, J. L., Cunningham, J. E., Brewer, H., et al. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.184 · Cited by 120
A mouse model for calculating cross-organ beta doses from yttrium-90-labeled immunoconjugates
Hui, T. E., Fisher, D. R., Kuhn, J. A., Williams, L. E., Nourigat, C., Badger, C. C., Beatty, B., & Beatty, J. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3+<1121::aid-cncr2820731353>3.0.co;2-q · Cited by 115
Pilot trial of murine monoclonal antibodies in patients with advanced melanoma.
Goodman, G. E., Beaumier, P. L., Hellström, I., et al. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.3.340 · Cited by 113
Development of human anti‐murine antibody (HAMA) response in patients
Tjandra, J. J., Ramadi, L., & McKenzie, I. F. C. (1990) · Immunology and Cell Biology · doi:10.1038/icb.1990.50 · Cited by 112
Interference by human anti-mouse antibody in two-site immunoassays
Kricka, L. J., Schmerfeld‐Pruss, D., Senior, M. B., Goodman, D. B. P., & Kaladas, P. M. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.6.892 · Cited by 102
Self-citationPrimus, F. J., Kelley, E. A., Hansen, H. J., & Goldenberg, D. M. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.2.257 · Cited by 101
Hunter, W. M. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92565-9 · Cited by 93
Scheinberg, D. A., Straus, D. J., Yeh, S.-D., Divgi, C. R., Garin‐Chesa, P., Graham, M. C., Pentlow, K. S., Coit, D. G., Oettgen, H. F., & Old, L. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.5.792 · Cited by 89
Stragliotto, G., Vega, F., Stasiecki, P., Gropp, P., Poisson, M., & Delattre, J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00592-7 · Cited by 82
Polyethylene Glycol Modification: Relevance of Improved Methodology to Tumour Targeting
Francis, G. E., Delgado, C., Fisher, D., Malik, F., & Agrawal, A. K. (1996) · Journal of drug targeting · doi:10.3109/10611869608996824 · Cited by 82
Antibody multispecificity in immunoassay interference
Levinson, S. S. (1992) · Clinical Biochemistry · doi:10.1016/0009-9120(92)80048-l · Cited by 81
Generation, Characterization, and in Vivo Studies of Humanized Anticarcinoma Antibody CC49
Kashmiri, S. V. S., SHU, L., PADLAN, E. A., Milenic, D. E., Schlom, J., & Hand, P. H. (1995) · Hybridoma · doi:10.1089/hyb.1995.14.461 · Cited by 81
Circulating Antibodies to Bovine Albumin in Ulcerative Colitis and Crohn's Disease
Falchuk, K. R., & Isselbacher, K. J. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80394-0 · Cited by 76
Circulating antibodies to cow's milk proteins in ulcerative colitis
Jewell, D. P., & Truelove, S. C. (1972) · Gut · doi:10.1136/gut.13.10.796 · Cited by 75
Larsson, A. O., & Mellstedt, H. (1992) · Hybridoma · doi:10.1089/hyb.1992.11.33 · Cited by 64
Intranasal Salcatonin (Salmon Calcitonin)
Plosker, G. L., & McTavish, D. (1996) · Drugs & Aging · doi:10.2165/00002512-199608050-00006 · Cited by 64
Czernichow, P., Vandalem, J. L., & Hennen, G. P. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-2-387 · Cited by 62
Vaidya, H. C., & Beatty, B. G. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1737 · Cited by 62
Boerman, O. C., Segers, M. F., Poels, L. G., Kenemans, P., & Thomas, C. M. G. (1990) · Clinical Chemistry · doi:10.1093/clinchem/36.6.888 · Cited by 61
Kenemans, P., van Kamp, G. J., Oehr, P., & Verstraeten, R. A. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.12.2509 · Cited by 61
Heterophilic Antibodies Interfering With Radioimmunoassay: A False-Positive Pregnancy Test
Vladutiu, A. O. (1982) · JAMA · doi:10.1001/jama.248.19.2489 · Cited by 59
Immunopharmacology: Immunomodulation and Immunotherapy
Ballow, M. C. (1997) · JAMA · doi:10.1001/jama.1997.03550220214027 · Cited by 58
ZWEIG, M. H., Csákó, G., Benson, C. C., Weintraub, B. D., & Kahn, B. B. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.6.840 · Cited by 57
van Zaanen, H. C. T., Koopmans, R. P., Aarden, L. A., Rensink, H. J. A. M., Stouthard, J. M., Warnaar, S. O., Lokhorst, H. M., & van Oers, M. H. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118932 · Cited by 57
HETEROPHILIC ANTIBODIES CAUSING FALSELY RAISED THYROID-STIMULATING-HORMONE RESULT
Hedenborg, G., Pettersson, T., & Carlström, A. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90696-2 · Cited by 57
Kimball, J. A., Norman, D. J., Shield, C. F., Schroeder, T., Lisi, P. J., Garovoy, M. R., O'Connell, J. B., Stuart, F. P., McDiarmid, S. V., & Wall, W. J. (1995) · Transplant Immunology · doi:10.1016/0966-3274(95)80027-1 · Cited by 55
Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6
Legouffe, É., Liautard, J., GAILLARD, J. P., Rossi, J.-F., Wijdenes, J., Bataille, R., Klein, B., & Brochier, J. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06145.x · Cited by 54
Phase I study of a murine monoclonal anti-lipid A antibody in bacteremic and nonbacteremic patients
Harkonen, S., Scannon, P. J., Mischak, R. P., S̄pitler, L. E., Foxall, C., Kennedy, D., & Greenberg, R. N. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.5.710 · Cited by 51
Kuroki, M., Matsumoto, Y., Arakawa, F., Haruno, M., Murakami, M., Kuwahara, M., Ozaki, H., Senba, T., & Matsuoka, Y. (1995) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)00301-c · Cited by 44
Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies
Fiad, T. M., Duffy, J., & McKenna, T. J. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02563.x · Cited by 44
Antibodies as a source of analytical errors.
Kohse, K. P., & Wisser, H. (1990) · PubMed · Cited by 43
Persistent Problems with the Specificity of Immunometric TSH Assays
Laurberg, P. (1993) · Thyroid · doi:10.1089/thy.1993.3.279 · Cited by 38
False Hyperthyrotropinemia Induced by Heterophilic Antibodies against Rabbit Serum
SCHAISON, G., THOMOPOULOS, P., Moulias, R., & Feinstein, M. C. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-200 · Cited by 37
Heterophilic Serum Antibodies: A Cause for Falsely Elevated Serum Thyrotropin Levels
BRENNAN, M. D., Klee, G. G., Preissner, C. M., & HAY, I. D. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65044-7 · Cited by 35
ZWEIG, M. H., Csákó, G., & Spero, M. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.12.2589 · Cited by 31
Sosolik, R. C., Hitchcock, C. L., & Becker, W. J. (1997) · American Journal of Clinical Pathology · doi:10.1093/ajcp/107.5.506 · Cited by 27
Csákó, G., Weintraub, B. D., & ZWEIG, M. H. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.7.1481 · Cited by 25
Suzuki, E., & Naiki, M. (1984) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a134571 · Cited by 24
Interference in a two-site immunoradiometric assay for thyrotropin in a child.
Cusick, C. F., Mistry, K., & Addison, G. M. (1985) · Clinical Chemistry · doi:10.1093/clinchem/31.2.348 · Cited by 22
Studies on heterophile antibodies in rheumatoid arthritis
Nishimaki, T., Kano, K., & Milgrom, F. (1978) · Arthritis & Rheumatism · doi:10.1002/art.1780210604 · Cited by 16
Antibody Interference in a Two-Site Immunometnc Assay for Thyrotrophin
John, R., Henley, R., & Barron, N. P. (1989) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328902600409 · Cited by 15
CA 125 determined by three methods in samples from patients with human anti-mouse antibodies (HAMA)
Turpeinen, U., Lehtovirta, P., & Stenman, U. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.11.1667 · Cited by 14
Interference in immunoenzymometric assays caused by IgM anti-mouse IgG antibodies.
Rc, M., Fj, R., & Cm, M. (1988) · PubMed · Cited by 14
Massuger, L. F. A. G., Thomas, C. M. G., Segers, M. F., Corstens, F. H. M., Verheijen, R. H. M., Kenemans, P., & Poels, L. G. (1992) · PubMed · Cited by 13
A Case of Graves' Disease with False Hyperthyrotropinemia Who Developed Silent Thyroiditis.
Iitaka, M., Ishii, J., SHIKAWA, N., Yoshimura, H., Momotani, N., SAITOU, H., & Ito, K. (1991) · Endocrinologia Japonica · doi:10.1507/endocrj1954.38.667 · Cited by 11
Monoclonal antibodies in human organ transplantation and auto-immune diseases.
Wijdenes, J., Roy, C., Morel-Fourrier, B., & Racadot, E. (1992) · PubMed · Cited by 6
Lang, G. M., Kierek‐Jaszczuk, D., Rector, E. S., Milton, A. D., Emmrich, F., & Sehon, A. H. (1992) · Immunology Letters · doi:10.1016/0165-2478(92)90057-u · Cited by 3
Cited by
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
Troponin: the biomarker of choice for the detection of cardiac injury
Babuin, L., & Jaffe, A. S. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050141 · Cited by 686
Wang, F., Lu, C.-H., & Willner, I. (2014) · Chemical Reviews · doi:10.1021/cr400354z · Cited by 649
The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry
Hoofnagle, A. N., & Wener, M. H. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.003 · Cited by 561
Electronic detection of DNA by its intrinsic molecular charge
Fritz, J., Cooper, E. B., Gaudet, S., Sorger, P. K., & Manalis, S. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232276699 · Cited by 443
Metadata
- Authors
- Kricka, L. J.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-07-01
- Volume
- 45
- Issue
- 7
- Pages
- 942-956
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W1925315080
- Cited by
- 586
- References
- 60
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.